The objective of the present study was to evaluate quality and yield attributes of Mexican beef carcasses to serve as a benchmark for production in the Mexican beef cattle industry. Seven packing plants were surveyed nationwide. Carcass yield and quality traits were assessed in the cooler at approximately 24 h postmortem. Results indicated that around 90% of the beef slaughter population in Mexico has a strong Bos indicus genetic background. Moreover, 71.6% of the surveyed cattle are presented for slaughter at a BW between 400 and 500 kg. Chilled carcass weight was between 220 and 340 kg in 88.9% of the surveyed population. According to European beef carcass grading standards, carcass conformation varied from poor to good in 82% of the carcasses, whereas in 17.8% the conformation was very good or excellent. In 60.7% of the surveyed carcasses the KPH was 2% or less. The subcutaneous fat depth was 1 cm or less in 90% of the carcasses. In 71.8% of the carcasses the LMA was of 80 cm(2) or less, whereas only 8.6% had LMA values of 90 cm(2) or greater. Carcass maturity score USDA B(100) or less was found in 92.4% of the evaluated carcasses, whereas 28.5% were graded as USDA A(100)/B(00). A total of 93.6% of the sample had marbling scores of 300 or less, corresponding to the categories slight, practically devoid, or traces. Only 12.9% of the carcasses exhibited a yellow fat cover. In the remaining 87.1% the fat cover was white or beige. The backfat layer was uniform in 43.2% of the carcasses, whereas 55.9% had an uneven fat cover. Information from this survey provided data that could serve as a means to develop a yield and quality evaluation program that can be further developed into a value system for Mexican beef carcasses and live cattle.

No abstract

No abstract

Erythropoietin is a glycoproteic hormone that regulates hematopoiesis by acting on its specific receptor (EpoR). The expression of EpoR in the central nervous system (CNS) suggests a role for this hormone in the brain. Recently, we developed a new Epo variant without hematopoietic activity called EpoL, which showed marked neuroprotective effects against oxidative stress in brain ischemia related models. In this study, we have evaluated the neuroprotective effects of EpoL against oxidative stress induced by chronic treatment with A β . Our results show that EpoL was neuroprotective against A β -induced toxicity by a mechanism that implicates EpoR, reduction in reactive oxygen species, and reduction in astrogliosis. Furthermore, EpoL treatment improved calcium handling and SV2 levels. Interestingly, the neuroprotective effect of EpoL against oxidative stress induced by chronic A β treatment was achieved at a concentration 10 times lower than that of Epo. In conclusion, EpoL, a new variant of Epo without hematopoietic activity, is of potential interest for the treatment of diseases related to oxidative stress in the CNS such as Alzheimer disease.

No abstract